Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring NK cell activity in patients with hematological malignancies.
Viel S, Charrier E, Marçais A, Rouzaire P, Bienvenu J, Karlin L, Salles G, Walzer T. Viel S, et al. Among authors: charrier e. Oncoimmunology. 2013 Sep 1;2(9):e26011. doi: 10.4161/onci.26011. Epub 2013 Sep 12. Oncoimmunology. 2013. PMID: 24327939 Free PMC article. Review.
Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.
Besson L, Mery B, Morelle M, Rocca Y, Heudel PE, You B, Bachelot T, Ray-Coquard I, Villard M, Charrier E, Parant F, Viel S, Garin G, Mayet R, Perol D, Walzer T, Tredan O, Marçais A. Besson L, et al. Among authors: charrier e. J Immunol. 2021 May 15;206(10):2265-2270. doi: 10.4049/jimmunol.2001215. Epub 2021 Apr 30. J Immunol. 2021. PMID: 33931486 Clinical Trial.
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
Viel S, Marçais A, Guimaraes FS, Loftus R, Rabilloud J, Grau M, Degouve S, Djebali S, Sanlaville A, Charrier E, Bienvenu J, Marie JC, Caux C, Marvel J, Town L, Huntington ND, Bartholin L, Finlay D, Smyth MJ, Walzer T. Viel S, et al. Among authors: charrier e. Sci Signal. 2016 Feb 16;9(415):ra19. doi: 10.1126/scisignal.aad1884. Sci Signal. 2016. PMID: 26884601
T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow.
Daussy C, Faure F, Mayol K, Viel S, Gasteiger G, Charrier E, Bienvenu J, Henry T, Debien E, Hasan UA, Marvel J, Yoh K, Takahashi S, Prinz I, de Bernard S, Buffat L, Walzer T. Daussy C, et al. Among authors: charrier e. J Exp Med. 2014 Mar 10;211(3):563-77. doi: 10.1084/jem.20131560. Epub 2014 Feb 10. J Exp Med. 2014. PMID: 24516120 Free PMC article.
Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and Pathogens.
Zannetti C, Roblot G, Charrier E, Ainouze M, Tout I, Briat F, Isorce N, Faure-Dupuy S, Michelet M, Marotel M, Kati S, Schulz TF, Rivoire M, Traverse-Glehen A, Luangsay S, Alatiff O, Henry T, Walzer T, Durantel D, Hasan U. Zannetti C, et al. Among authors: charrier e. J Immunol. 2016 Jul 1;197(1):356-67. doi: 10.4049/jimmunol.1502301. Epub 2016 May 25. J Immunol. 2016. PMID: 27226092
Late-onset hemophagocytic lymphohistiocytosis with neurological presentation.
Benezech S, Walzer T, Charrier E, Heidelberg D, De Saint-Basile G, Bertrand Y, Belot A. Benezech S, et al. Among authors: charrier e. Clin Case Rep. 2017 Sep 12;5(11):1743-1749. doi: 10.1002/ccr3.1135. eCollection 2017 Nov. Clin Case Rep. 2017. PMID: 29152263 Free PMC article.
IL-7 enhances survival of human CD56bright NK cells.
Michaud A, Dardari R, Charrier E, Cordeiro P, Herblot S, Duval M. Michaud A, et al. Among authors: charrier e. J Immunother. 2010 May;33(4):382-90. doi: 10.1097/CJI.0b013e3181cd872d. J Immunother. 2010. PMID: 20386468
50 results